Related Experiment Video
Updated: Aug 6, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
[Myelofibrosis as a cause of non-cirrhotic portal hypertension]
Juan José Quiroz-Leyva1, Edgar Fermín Yan-Quiroz2, José Richard Tenazoa-Villalobos1
1Hospital Víctor Lazarte Echegaray, Trujillo, Perú; Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo, Perú.
Abstract:
Primary myelofibrosis is a chronic myeloproliferative neoplasm characterised by extramedullary hematopoiesis. Portal hypertension represents a significant cause of mortality in these patients. Diagnosis of portal hypertension is typically based on clinical manifestations and is often confirmed by upper gastrointestinal endoscopy, which allows for the identification of oesophageal varices and facilitates endoscopic intervention. Management options include general supportive measures, chemotherapy, splenectomy, and radiation therapy. This report describes a 53-year-old woman with a history of myelofibrosis who presented with abdominal pain and anaemia. Upper gastrointestinal video endoscopy revealed oesophageal varices, and subsequent confirmation of portal hypertension prompted a percutaneous liver biopsy, which demonstrated myelofibrosis. After appropriate management, the patient had a favourable clinical outcome.
Related Concept Videos
Portal Hypertension
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...

